These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 15000346)
41. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation. Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595 [TBL] [Abstract][Full Text] [Related]
42. [Progress in diagnosis of disseminated intravascular coagulation (DIC)--diagnostic criteria of DIC]. Koyama T; Aoki N Nihon Rinsho; 1993 Jan; 51(1):43-9. PubMed ID: 8433527 [TBL] [Abstract][Full Text] [Related]
47. Coagulation in patients with severe sepsis. Levi M; Poll Tv Semin Thromb Hemost; 2015 Feb; 41(1):9-15. PubMed ID: 25590524 [TBL] [Abstract][Full Text] [Related]
49. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation. Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701 [TBL] [Abstract][Full Text] [Related]
50. Fresh frozen plasma in patients with disseminated intravascular coagulation or in patients with liver diseases. Mueller MM; Bomke B; Seifried E Thromb Res; 2002 Oct; 107 Suppl 1():S9-17. PubMed ID: 12379287 [TBL] [Abstract][Full Text] [Related]
51. Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Vervloet MG; Thijs LG; Hack CE Semin Thromb Hemost; 1998; 24(1):33-44. PubMed ID: 9515778 [TBL] [Abstract][Full Text] [Related]
52. Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats. Asakura H; Suga Y; Aoshima K; Ontachi Y; Mizutani T; Kato M; Saito M; Morishita E; Yamazaki M; Takami A; Miyamoto K; Nakao S Crit Care Med; 2002 Jan; 30(1):161-4. PubMed ID: 11902257 [TBL] [Abstract][Full Text] [Related]
53. Update on the treatment of disseminated intravascular coagulation. Franchini M; Manzato F Hematology; 2004 Apr; 9(2):81-5. PubMed ID: 15203862 [TBL] [Abstract][Full Text] [Related]
55. Pathogenesis and diagnosis of disseminated intravascular coagulation. Levi M Int J Lab Hematol; 2018 May; 40 Suppl 1():15-20. PubMed ID: 29741245 [TBL] [Abstract][Full Text] [Related]
56. [Coagulation tests in septic surgical patients]. Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805 [TBL] [Abstract][Full Text] [Related]
57. Disseminated intravascular coagulation: an update on pathogenesis and diagnosis. Levi M; Sivapalaratnam S Expert Rev Hematol; 2018 Aug; 11(8):663-672. PubMed ID: 29999440 [TBL] [Abstract][Full Text] [Related]
58. [Anti DIC therapy]. Yahata M; Sakamoto Y Nihon Rinsho; 2016 Feb; 74(2):257-61. PubMed ID: 26915249 [TBL] [Abstract][Full Text] [Related]
59. Pathogenesis, diagnosis, and management of disseminated intravascular coagulation: a literature review. Dalainas I Eur Rev Med Pharmacol Sci; 2008; 12(1):19-31. PubMed ID: 18401969 [TBL] [Abstract][Full Text] [Related]
60. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Levi M; van der Poll T; ten Cate H; van Deventer SJ Eur J Clin Invest; 1997 Jan; 27(1):3-9. PubMed ID: 9041370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]